Colossal Biosciences, aiming to revive extinct species, secures $200M, becoming Texas's first "decacorn."

Colossal Biosciences, a company aiming to revive extinct species like the woolly mammoth and dodo through genetic engineering, has raised $200 million in Series C funding, boosting its valuation to $10.2 billion. This makes it Texas's first "decacorn," a term for privately-held companies valued over $10 billion. The funding will support lab expansions and team growth to advance conservation and combat extinction.

2 months ago
18 Articles